◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › E › EVH

Evolent Health, Inc (EVH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

NYSE · DATA UPDATED 2026-10-02

Evolent Health, Inc (EVH) operates in the NYSE industry and is headquartered in Arlington, United States with about 4,200 employees. Its market capitalization is roughly $486 million. In the fiscal year ended 2025-12-31, EVH reported $1.9B in revenue and ($535M) in net income.

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management.

Interactive charts & full statements → Open the EVH valuation workbench →

EVH Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Total Revenue	$2.1B	$1.9B	$2.6B	$2.0B	$1.4B	$908M	$925M	$687M	$627M	$435M	$254M	$97M	$101M	$26M	$8M
Gross Profit	$271M	$284M	$367M	$460M	$317M	$250M	$228M	$174M	$299M	$166M	$99M	$39M	$28M	($4M)	($3M)
Gross Margin %	12.9%	15.1%	14.4%	23.4%	23.4%	27.6%	24.7%	25.3%	47.7%	38.1%	39.0%	40.8%	27.5%	-16.9%	-35.1%
Operating Income (EBIT)	($29M)	($4M)	($40M)	($71M)	$4M	($42M)	($263M)	($309M)	($47M)	($73M)	($237M)	($43M)	($25M)	($21M)	($20M)
Operating Margin %	-1.4%	-0.2%	-1.6%	-3.6%	0.3%	-4.7%	-28.4%	-45.0%	-7.6%	-16.8%	-93.4%	-44.4%	-25.0%	-82.4%	-235.1%
Net Income	($505M)	($535M)	($62M)	($113M)	($19M)	($38M)	($334M)	($302M)	($53M)	($61M)	($160M)	$332M	($25M)	$20M	($19M)
Net Margin %	-24.1%	-28.5%	-2.4%	-5.8%	-1.4%	-4.1%	-36.1%	-44.0%	-8.4%	-14.0%	-62.8%	343.2%	-25.0%	78.0%	-230.8%
EBITDA	($317M)	($361M)	$85M	($25M)	$44M	$56M	($241M)	($255M)	($4M)	($40M)	($220M)	($32M)	($25M)	($20M)	($20M)
Earnings Per Share (EPS)	$-4.43	$-4.68	$-0.54	$-1.02	$-0.20	$-0.44	$-3.94	$-3.67	$-0.68	$-0.94	$-3.55	$7.21	$-0.66	$0.52	$-0.50
Shares Outstanding (M)	113M	114M	115M	111M	94M	86M	85M	82M	77M	64M	45M	46M	38M	38M	38M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EVH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$653M	$496M	$469M	$480M	$444M	$484M	$647M	$621M
Gross Profit	$81M	$62M	$52M	$76M	$77M	$102M	$76M	$81M
Gross Margin %	12.4%	12.5%	11.1%	15.8%	17.3%	21.2%	11.7%	13.0%
Operating Income (EBIT)	($10M)	($10M)	($10M)	$1M	$3M	($2M)	($19M)	($16M)
Operating Margin %	-1.5%	-2.0%	-2.1%	0.1%	0.6%	-0.3%	-2.9%	-2.6%
Net Income	($28M)	($27M)	($429M)	($21M)	($20M)	($65M)	($23M)	($23M)
Net Margin %	-4.3%	-5.4%	-91.5%	-4.3%	-4.5%	-13.4%	-3.5%	-3.7%
EBITDA	$13M	$14M	($367M)	$23M	$15M	($29M)	$13M	$12M
Earnings Per Share (EPS)	$-0.25	$-0.24	$-3.76	$-0.18	$-0.17	$-0.56	$-0.20	$-0.20
Shares Outstanding (M)	113M	112M	114M	114M	116M	115M	115M	115M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EVH Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Cash from Operations (CFO)	$53M	$39M	$19M	$143M	($12M)	$39M	($16M)	($43M)	($21M)	($28M)	($36M)	($20M)	($75M)	($14M)	($13M)
Capital Expenditures (CapEx)	$36M	$34M	$25M	$29M	$38M	$25M	$29M	$36M	$40M	$28M	$16M	$7M	$11M	$10M	$2M
Free Cash Flow (FCF)	$17M	$5M	($6M)	$114M	($50M)	$14M	($46M)	($78M)	($60M)	($56M)	($51M)	($26M)	($86M)	($24M)	($15M)
FCF Margin %	0.8%	0.2%	-0.2%	5.8%	-3.7%	1.5%	-4.9%	-11.4%	-9.6%	-12.8%	-20.1%	-27.2%	-85.4%	-93.8%	-180.9%
Dividends Paid	$2M	$11M	$20M	$19M	$15M	$1M	$20M	$61M	—	$0M	$0M	$0M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EVH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	($10M)	($1M)	$49M	$16M	($30M)	$5M	($26M)	$19M
Capital Expenditures (CapEx)	$13M	$6M	$8M	$9M	$9M	$9M	$6M	$6M
Free Cash Flow (FCF)	($24M)	($7M)	$41M	$7M	($39M)	($4M)	($32M)	$12M
FCF Margin %	-3.6%	-1.5%	8.8%	1.4%	-8.8%	-0.8%	-5.0%	2.0%
Dividends Paid	$0M	$0M	$0M	$2M	$5M	$5M	$5M	$5M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EVH Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Total Assets	$2.0B	$1.9B	$2.5B	$2.7B	$1.8B	$1.4B	$1.5B	$1.5B	$1.7B	$1.3B	$1.2B	$1.0B	$38M	$102M	$16M
Cash & Cash Equivalents	$116M	$152M	$104M	$193M	$188M	$266M	$333M	$101M	$228M	$238M	$135M	$146M	$15M	$68M	$5M
Total Liabilities	$1.6B	$1.5B	$1.5B	$1.6B	$958M	$726M	$855M	$569M	$533M	$266M	$288M	$81M	$40M	$71M	$11M
Total Debt (Short + Long-Term)	$968M	$986M	$689M	$607M	$420M	$223M	$297M	$300M	$344M	$243M	$241M	$0M	$120M	$10M	$0M
Total Shareholders' Equity	$383M	$415M	$1.0B	$1.1B	$859M	$694M	$620M	$922M	$1.2B	$1.0B	$912M	$649M	($2M)	$31M	$5M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EVH viewer.

Other Companies in Software & IT Services

PANL · Pangaea Logistics Solutions Ltd. - — $496 million
JEMI · JPMorgan Emerging Markets Div Inc — £493 million
PCGH · Polar Capital Glb Healthcare Ord — £493 million
MTC · MMTec, Inc. - — $492 million
FAC · Factorial Energy Inc. - — $478 million
CNTL · Centiel AG — CHF 472 million
MASS · 908 Devices Inc. - — $465 million
ALLT · Allot Ltd. - — $428 million

← EVGO All “E” companies EVHY →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.